健康大视野·医学分册2023,Issue(9) :13-15.

普米克令舒联合特布他林雾化吸入治疗小儿支气管肺炎对住院时间的影响

苏建梅 周纹
健康大视野·医学分册2023,Issue(9) :13-15.

普米克令舒联合特布他林雾化吸入治疗小儿支气管肺炎对住院时间的影响

苏建梅 1周纹2
扫码查看

作者信息

  • 1. 阳谷县人民医院儿科一区,山东 聊城 252300
  • 2. 阳谷县疾病预防控制中心计免科,山东 聊城 252300
  • 折叠

摘要

目的:探究小儿支气管肺炎采用普米克令舒合特布他林雾化吸入治疗的临床效果以及对住院时间的影响.方法:2021年1月~2022年8月,选小儿支气管肺炎患儿一共60例,经随机数字表法,30例对照组,30例观察组.对照组实施常规综合治疗,观察组行普米克令舒联合特布他林雾化吸入治疗,比较治疗效果、症状消失时间和住院时间、肺功能改善情况.结果:①观察组治疗总有效率高于对照组(P<0.05);②湿罗音、双肺哮鸣音、气促、咳嗽等症状消失时间和住院时间较对照组,观察组显著较短(P<0.05).结论:普米克令舒联合特布他林雾

Abstract

Objective To explore the clinical effect of aerosol inhalation of pulmicort and terbutaline in the treatment of children with bronchopneumonia and its impact on hospital stay.Methods From January 2021 to August 2022, a total of 60 children with bronchopneumonia were selected, 30 cases in the control group and 30 cases in the observation group.The control group was given routine comprehensive treatment, and the observation group was given pulmicort combined with terbutaline aerosol inhalation.The treatment effect, time of symptom disappearance, hospital stay and improvement of lung function were compared.Results ① The total effective rate of treatment in the observation group was higher than that in the control group (P<0.05); ② The disappearance time and hospitalization time of wet rale, double lung wheeze, shortness of breath, cough and other symptoms in the observation group were significantly shorter than those in the control group (P<0.05).Conclusion: Pulmicort combined with terbutaline aerosol inhalation can achieve prominent effect in the treatment of children with bronchopneumonia and shorten the hospitalization time of children.

关键词

普米克令舒/特布他林/雾化吸入/小儿/支气管肺炎/住院时间

Key words

Pumico Lingshu/Tebutaline/Atomization inhalation/children/Bronchial pneumonia/Length of stay

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量13
段落导航相关论文